GlassScriptPhysician profile
Kristyn Turner
NPI 1336875772
$1,244.58
in general payments reported to CMS, 2019-2025
15 companies · $840 in 2025
The $840 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $59.23 · 2024: $345 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,244.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $472.11 | 2024-2025 | |
| Exact Sciences Corporation | $187.89 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $165.45 | 2023-2025 | Zepbound, Mounjaro, Trulicity |
| Merck Sharp & Dohme LLC | $96.94 | 2024-2025 | Capvaxive, Vaxelis, Gardasil 9 |
| Abbvie INC. | $71.60 | 2025 | |
| Novo Nordisk INC | $41.21 | 2023-2024 | Rybelsus, Ozempic |
| Globus Medical, INC. | $36.87 | 2025 | Senza |
| Otsuka America Pharmaceutical, INC. | $26.39 | 2025 | Rexulti |
| Eisai INC. | $24.54 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.93 | 2025 | |
| Glaxosmithkline, LLC. | $21.69 | 2024 | Arexvy, Shingrix |
| Dynavax Technologies Corporation | $21.60 | 2025 | Heplisav-B |
| Gilead Sciences, INC. | $20.96 | 2025 | |
| Sanofi Pasteur INC. | $20.42 | 2025 | |
| Nevro Corp. | $13.98 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristyn Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.